from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3839/-

LFCtreatmentdescriptionclass of inhibitor

-0.125

Amikacinug/mL Amikacintranslation

0.057

Cap5-10ug/mL Capreomycintranslation

0.049

Rox10-50 ug/mL Roxithromycintranslation

-0.074

SM2-5 ug/mL Streptomycintranslation

0.051

Tet5-10 ug/mL Tetracyclinetranslation

0.023

Rif0.2-5ug/mL Rifampicintranscription

-0.260

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.392

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.413

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.403

CPZ10-50 ug/mL Chlorpromazinerespiration

3.582

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.314

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.813

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.439

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.637

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.453

Econazole10-24 ug/mL Econazole (azole drug)respiration

3.002

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.500

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.031

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.434

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.960

KCN5-20 ug/mL Potassium cyaniderespiration

-0.092

NaN30.2-2 mM Sodium aziderespiration

-0.090

Nigericin50 uM Nigericinrespiration

-0.344

TRC10-150 ug/mL Triclosanrespiration

-0.317

TRZ10-25 ug/mL Thioridazinerespiration

1.156

Valinomycin0.5-10 uM Valinomycinrespiration

-0.875

ZnSO42 mM ZnSO4respiration

-0.385

menadione6-10 ug/mL Menadionerespiration

2.695

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.289

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.593

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.321

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.263

NRP_1Non-replicating persistence stage 1dosRassociated

-0.246

Amp0.2mg/mL AmpicillincellWall

-0.212

Cephalexin20-100 ug/mL CephalexincellWall

-0.275

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.886

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.150

EMB10-20 ug/mL EthambutolcellWall

-0.451

Eta12-40 ug/mL EthionamidecellWall

-0.265

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.368

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.472

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.357

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.352

BZA0.12 mg/mL BenzamidearomaticAmides

-0.357

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.052

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.414

H2O24 mM hydrogen peroxideDNAdamaging

-0.190

Levo10 ug/mL LevofloxacinDNAdamaging

-0.473

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.416

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.133

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.378

UVUV-irradiationDNAdamaging

0.564

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.350

Antimycin12.5-50 ug/mL Antimycin A?

-0.171

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.266

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.439

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.086

PA8240.2-2 ug/mL PA-824?

-0.397

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.369

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.171

Verapamil50 uM Verapamil?

-0.223

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.114

methoxatin10-20 ug/mL Methoxatin?